Conference · Philadelphia, Pennsylvania
Rare Disease Collaboration
Health · Medicine
Key numbers
- Editions on record
- 2first in 2015
About Rare Disease Collaboration
With more than 6,000 rare diseases recognized by the NIH, the market for orphan and ultra-orphan indications represents a major growth area for pharma and biotech companies. But low patient numbers combined with the urgency of unmet medical needs can make standard clinical trial procedures unfeasible. ExL Pharma’s 3rd Rare Disease Collaboration Summit gives you the tools you need to build lasting partnerships with patient advocacy groups in order to construct more flexible and patient-centric clinical trial protocols and accelerate the regulatory approval of your orphan drug. This event hosts the formation of working group relationships that harness the collective resources of industry and patient advocates, creating a working framework for shaping legislation and convincing regulators. Build best practice outputs that outlive the meeting!
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2016 | 11–12 Jul 2016 | Sonesta Hotel Philadelphia Philadelphia, Pennsylvania | — | — |
| 2015 | 15–16 Jul 2015 | Hilton Philadelphia at Penn's Landing Philadelphia, Pennsylvania | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Rare Disease Collaboration?
The next dates haven't been confirmed. The last edition we have on record was 11–12 Jul 2016.
Where is it held?
The last edition we have was at Sonesta Hotel Philadelphia, Philadelphia, Pennsylvania.